SITC Resource Library

On August 23, 2022, leading experts from the SITC Lung Cancer and Mesothelioma Immunotherapy Guideline Expert Panel presented "Practical Management Pearls for Immunotherapy for the Treatment of Lung Cancer and Mesothelioma — SITC CPG Webinar." This high-level webinar was designed to teach attendees how to appraise and classify organ-specific considerations for immunotherapy agents and toxicities, identify and manage clinically significant uncommon toxicities, and determine optimal sequencing of immunotherapies in relapsed and/or refractory disease, as discussed in the Clinical Practice Guideline (CPG). The recorded webinar and presentation slides are available below.

Webinar Faculty

• Moderator: Ramaswamy Govindan, MD – Washington University School of Medicine (Expert Panel Chair)
• Sarah B. Goldberg, MD, MPH – Yale Cancer Center (Expert Panel Member)
• Jyoti D. Patel, MD – Northwestern University (Expert Panel Member)

• Practical considerations for diagnostic testing and classification in Lung Cancer and Mesothelioma and the implications for immunotherapy treatment planning
• Appropriately managing challenging and/or uncommon toxicities/irAEs associated with immunotherapy in Lung Cancer and Mesothelioma
• Determining optimal sequencing of immunotherapies in all stages of Lung Cancer and Mesothelioma treatment, including treatment for persistent or relapsed/refractory disease after initial therapy

The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/15/2021).

The SITC Clinical Practice Guidelines are produced by SITC and have no funding from outside sources.